• Je něco špatně v tomto záznamu ?

Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing

J. Linhartova, L. Hovorkova, S. Soverini, A. Benesova, M. Jaruskova, H. Klamova, J. Zuna, K. Machova Polakova,

. 2015 ; 14 (-) : 89. [pub] 20150418

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu dopisy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010248

Grantová podpora
NT11555 MZ0 CEP - Centrální evidence projektů

In chronic myeloid leukemia, the identification of individual BCR-ABL1 fusions is required for the development of personalized medicine approach for minimal residual disease monitoring at the DNA level. Next generation sequencing (NGS) of amplicons larger than 1000 bp simplified and accelerated a process of characterization of patient-specific BCR-ABL1 genomic fusions. NGS of large regions upstream and downstream the individual breakpoints in BCR and ABL1 genes, respectively, also provided information about the sequence variants such are single nucleotide polymorphisms.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010248
003      
CZ-PrNML
005      
20191007160435.0
007      
ta
008      
160408s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12943-015-0363-8 $2 doi
024    7_
$a 10.1186/s12943-015-0363-8 $2 doi
035    __
$a (PubMed)25928096
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Linhartova, Jana $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic. jana.linhartova@uhkt.cz.
245    10
$a Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing / $c J. Linhartova, L. Hovorkova, S. Soverini, A. Benesova, M. Jaruskova, H. Klamova, J. Zuna, K. Machova Polakova,
520    9_
$a In chronic myeloid leukemia, the identification of individual BCR-ABL1 fusions is required for the development of personalized medicine approach for minimal residual disease monitoring at the DNA level. Next generation sequencing (NGS) of amplicons larger than 1000 bp simplified and accelerated a process of characterization of patient-specific BCR-ABL1 genomic fusions. NGS of large regions upstream and downstream the individual breakpoints in BCR and ABL1 genes, respectively, also provided information about the sequence variants such are single nucleotide polymorphisms.
650    _2
$a bcr-abl fúzní proteiny $x genetika $7 D016044
650    _2
$a vysoce účinné nukleotidové sekvenování $x metody $7 D059014
650    _2
$a lidé $7 D006801
650    _2
$a chronická myeloidní leukemie $x genetika $7 D015464
650    _2
$a jednonukleotidový polymorfismus $x genetika $7 D020641
655    _2
$a dopisy $7 D016422
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hovorkova, Lenka $u CLIP, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic. lenka.hovorkova@lfmotol.cuni.cz.
700    1_
$a Soverini, Simona $u Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. e A. Seragnoli", University of Bologna, Bologna, Italy. simona.soverini@tin.it.
700    1_
$a Benesova, Adela $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic. adela.brouckova@uhkt.cz.
700    1_
$a Jaruskova, Monika $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic. monika.jaruskova@uhkt.cz. Institute of Clinical and Experimental Hematology of First Faculty of Medicine and Institute of Hematology and Blood Transfusion, Charles University, Prague, Czech Republic. monika.jaruskova@uhkt.cz.
700    1_
$a Klamová, Hana $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic. hana.klamova@uhkt.cz. Institute of Clinical and Experimental Hematology of First Faculty of Medicine and Institute of Hematology and Blood Transfusion, Charles University, Prague, Czech Republic. hana.klamova@uhkt.cz. $7 xx0081721
700    1_
$a Zuna, Jan, $u CLIP, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic. jan.zuna@lfmotol.cuni.cz. $d 1971- $7 xx0036260
700    1_
$a Machová, Kateřina $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic. katerina.machova@uhkt.cz. Institute of Clinical and Experimental Hematology of First Faculty of Medicine and Institute of Hematology and Blood Transfusion, Charles University, Prague, Czech Republic. katerina.machova@uhkt.cz. $7 xx0139783
773    0_
$w MED00008245 $t Molecular cancer $x 1476-4598 $g Roč. 14, č. - (2015), s. 89
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25928096 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20191007160850 $b ABA008
999    __
$a ok $b bmc $g 1113677 $s 934616
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 14 $c - $d 89 $e 20150418 $i 1476-4598 $m Molecular cancer $n Mol Cancer $x MED00008245
GRA    __
$a NT11555 $p MZ0
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Možnosti archivace